Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Clinical Case Reports|October 22, 2020
Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor showing unfavorable outcomes despite immediate discontinuation of medicationYasutake Shinohara, Toshie Iijima, Shintaro Sakurai, et al.
International Journal of Cancer|July 19, 2002
Application of differential display to identify genes for lung cancer detection in peripheral bloodHiroko Matsunaga, Nanae Hangai, Yoshimasa Aso, et al.
Obesity Research & Clinical Practice|February 10, 2015
Alterations of plant sterols, lathosterol, oxidative stress and inflammatory markers after the combination therapy of ezetimibe and statin drugs in type 2 diabetic patientsRika Naruse, Ken-ichiro Hori, Tomoko Terasawa, et al.
International Journal of Clinical Practice|February 28, 2019
Impact of dapagliflozin, an SGLT2 inhibitor, on serum levels of soluble dipeptidyl peptidase-4 in patients with type 2 diabetes and non-alcoholic fatty liver diseaseYoshimasa Aso, Kanako Kato, Shintaro Sakurai, et al.
Internal Medicine (Tokyo, Japan)|February 9, 2022
Acute Exacerbation of Anemia with Parvovirus B19 Infection One Year after Sleeve Gastrectomy for Severe ObesityToshimitsu Shinzawa, Isao Usui, Kanako Hanawa, et al.
International Journal of Molecular Sciences|October 27, 2019
The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular CarcinomaTeruo Jojima, Sho Wakamatsu, Masato Kase, et al.
The American Journal of the Medical Sciences|May 17, 2005
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers effectively and directly potentiate superoxide scavenging by polymorphonuclear leukocytes from patients with type 2 diabetes mellitusToshihiko Inukai, Noboru Yoshida, Sadao Wakabayashi, et al.
Endocrine Journal|May 24, 2006
Profound reduction in T-helper (Th) 1 lymphocytes in peripheral blood from patients with concurrent type 1 diabetes and Graves' diseaseYoshimasa Aso, Hiromi Matsuura, Atsushi Momobayashi, et al.
The American Journal of the Medical Sciences|July 10, 2024
Diabetes with GLP-1R polymorphism (rs3765467) accompanied by myotonic dystrophy: A case of myotonic dystrophy with p.R131Q polymorphism at the glucagon-like peptide-1 receptor (rs3765467) resulting in marked effects of its agonist, dulaglutideKanako Kato, Teruo Jojima, Takahiko Kogai, et al.
Internal Medicine (Tokyo, Japan)|August 2, 2008
Extensive callosal infarction showing difficulty in knitting as an initial symptomKeisuke Suzuki, Yoshiteru Takiguchi, Tomoyuki Miyamoto, et al.
Pageof 12